Cite
HARVARD Citation
Geyer, C. et al. (2018). 21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer. NPJ breast cancer. pp. 1-6. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Geyer, C. et al. (2018). 21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer. NPJ breast cancer. pp. 1-6. [Online].